Related Experiment Video
Updated: Jul 16, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors,
Elizabeth Turner1, Victor Dishy, Cecilia P Chung
1Division of Clinical Pharmacology, Center of Health Services Research, Department of Biostatistics, 560 Robinson Research Building, Vanderbilt University School of Medicine, Nashville, TN, 37232-6602, USA.
Insights
Endothelial dysfunction in systemic lupus erythematosus patients is linked to corticosteroid use. This pilot study suggests long-term corticosteroid therapy may impair vascular endothelial function.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Vascular Biology
Background:
- Systemic lupus erythematosus (SLE) is associated with increased risk of premature coronary artery disease.
- Endothelial dysfunction is a common finding in SLE patients and a key contributor to atherosclerosis.
- Understanding factors influencing endothelial function in SLE is crucial for cardiovascular risk management.
Purpose of the Study:
- To investigate the relationship between endothelial function and disease activity in lupus patients.
- To assess the association between cardiovascular risk factors and endothelial function in this population.
- To explore the impact of specific SLE treatments, like corticosteroids, on endothelial health.
Main Methods:
- Evaluated 20 lupus patients, assessing clinical characteristics and cardiovascular risk factors.
- Measured brachial artery flow-mediated dilation using high-resolution ultrasound.
- Determined coronary calcification via electron-beam computed tomography.
Main Results:
- Median flow-mediated dilation was 3.6% (1.7%-7.7%).
- No significant correlation found between endothelial function and disease activity markers or general cardiovascular risk factors.
- A significant inverse association was observed between flow-mediated dilation and the duration of corticosteroid therapy (RHO = -0.44, p = 0.05).
Conclusions:
- Endothelial dysfunction in lupus patients may be associated with long-term corticosteroid exposure.
- These preliminary findings highlight corticosteroids as a potential factor contributing to vascular impairment in SLE.
- Further research is warranted to confirm these results and elucidate the mechanisms involved.
Objectives:
Endothelial dysfunction is frequently present in patients with systemic lupus erythematosus and may increase their risk of premature coronary artery disease. In this pilot study we have characterized the relationship between endothelial function, measures of disease activity, and cardiovascular risk factors in patients with lupus.
Methods:
Clinical characteristics and cardiovascular risk factors were evaluated in 20 patients with lupus. Flow-mediated dilation of the brachial artery was measured using high resolution ultrasound and the presence or absence of coronary calcification determined by electron-beam computed tomography. The relationship between these variables and flow-mediated dilation was determined using Spearman correlation coefficients (RHO) and Mann Whitney-Wilcoxon tests.
Results:
Twenty patients (17 female) median age (interquartile range) 42.5 (32.0-47.5) years were studied. The median flow-mediated vasodilation was 3.6% (1.7%-7.7%). In patients with coronary calcification (n = 6), flow-mediated dilation was 2.1% (-0.42%-3.6%) compared with 4.0% (3.5%-8.3%) in those without (p = 0.12). There was no significant relationship between flow-mediated dilation and markers of disease activity, duration of disease, and cardiovascular risk factors. Lower flow-mediated dilation was associated with duration of corticosteroid therapy (RHO = -0.44, p = 0.05).
Conclusions:
In these preliminary results, endothelial dysfunction is associated with long-term exposure to corticosteroids.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease III: Medical Management
